Shares in financial firm Stifel (SF) dropped 3% today after it was told to cough up $132.5 million in damages to a U.S.

Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million ...

Stock analysts at Stifel Nicolaus initiated coverage on shares of Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) in a research ...

Raymond James Financial Inc. purchased a new position in T. Rowe Price Ultra Short-Term Bond ETF (NYSEARCA:TBUX – Free Report ...

Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a ...

Stifel analyst Chris O’Cull downgraded Xponential Fitness (XPOF) to Hold from Buy with a price target of $12, down from $20. The firm says it ...

Stifel Financial on Thursday said it has been ordered to pay $132 million connection with allegations regarding investment recommendations. The Financial Industry Regulatory Authority, a U.S.

Contineum Therapeutics (Nasdaq: CTNM) is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for NI&I indications with significant unmet need. Contineum is ...

Fintel reports that on February 27, 2025, Stifel downgraded their outlook for Arko (NasdaqCM:ARKO) from Buy to Hold. Analyst ...

Neumora Therapeutics (NASDAQ:NMRA) fell ~11% in the premarket on Friday as Stifel downgraded the biotech after efficacy concerns prompted J&J (NYSE:JNJ) to discontinue a late-stage program called ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...